Lamond David Insider Trades

Insider Trading History

Track insider trading activity for Lamond David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $30.3k 29,423 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$88.3k 29,423 shares
$3.00
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $27.8k 27,000 shares
Last Trade
Jun 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.4k 27,000 shares
$1.09
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $49k 47,587 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.5k 47,587 shares
$1.88
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $27.8k 27,000 shares
Last Trade
Jun 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.1k 27,000 shares
$0.82
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $2.42M 2,347,545 shares
Last Trade
Dec 14, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23.5k 22,627 shares
$1.04
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $2.39M 2,324,918 shares
Last Trade
Dec 13, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$22.6k 22,627 shares
$1.00
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $2.37M 2,302,291 shares
Last Trade
Dec 12, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$23.1k 22,627 shares
$1.02
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $2.35M 2,279,664 shares
Last Trade
Dec 07, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.3k 19,123 shares
$1.01
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $2.33M 2,260,541 shares
Last Trade
Dec 06, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.5k 19,123 shares
$1.02
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $2.31M 2,241,418 shares
Last Trade
Dec 05, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.3k 19,123 shares
$1.01
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $2.29M 2,222,295 shares
Last Trade
Dec 01, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$13.5k 14,378 shares
$0.94
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $2.27M 2,207,917 shares
Last Trade
Nov 30, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.9k 14,378 shares
$0.90
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $2.26M 2,193,539 shares
Last Trade
Nov 29, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.1k 14,378 shares
$0.98
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $2.24M 2,179,161 shares
Last Trade
Aug 31, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$54.2k 41,026 shares
$1.32
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $2.2M 2,138,135 shares
Last Trade
Aug 30, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$53.7k 41,026 shares
$1.31
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $2.16M 2,097,109 shares
Last Trade
Aug 17, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$31.9k 24,766 shares
$1.29
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $2.13M 2,072,343 shares
Last Trade
Aug 16, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$151k 117,348 shares
$1.29
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $2.01M 1,954,995 shares
Last Trade
Aug 15, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$142k 107,886 shares
$1.32
$1.03
Quince Therapeutics
Quince Therapeutics QNCX
Director
Holding Value $27.8k 27,000 shares
Last Trade
May 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.7k 27,000 shares
$1.58
$1.03
Cortexyme
Cortexyme CRTX
Director
Holding Value $52.7k 27,000 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$87.2k 27,000 shares
$3.23
$1.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up